期刊文献+

γ-干扰素诱导蛋白-10融合蛋白的表达纯化及其生物学活性测定 被引量:2

Expression and purification of IP-10 fusion protein and identification of its biology activity
下载PDF
导出
摘要 目的表达大鼠γ-干扰素诱导蛋白-10(IP-10)融合蛋白,并测定其生物学活性。方法从大鼠脾细胞中提取总RNA,用RT-PCR方法得到IP-10cDNA,双酶切将其插入pET-32(a)+载体中。重组质粒pET-32a(+)-IP10经测序证实。将pET-32a(+)-IP10转化大肠杆菌BL21(DE3)中进行表达,目的蛋白经镍离子亲和层析柱纯化。微室跨膜迁移实验测定其生物学活性。结果测序表明,所构建的重组质粒pET-32a(+)-IP10序列完全正确,诱导表达的蛋白的相对分子量同预期分子量相同,微室跨膜迁移实验测定出IP-10融合蛋白对激活的T淋巴细胞具有良好的趋化活性。结论成功在大肠杆菌中表达了IP-10融合蛋白,并具有生物学活性。 【Objective】To express rat IFN-γ-inducible protein-10 (IP-10) fusion protein in E. coli. and analyze its biological activity.【Methods】Total RNA was isolated from rat spleen cells, and reverse transcription- PCR was performed based on the IP-10 nucleotide sequence, PCR products were cloned into the pET-32(a)+ vector after being digested by two restrictive enzymes of Kpn I and EcoR I. The sequence of recombinant plasmid pET-32a (+)-IP10 was verified by DNA sequencing, and then transformed into BL21 (DE3) cells.The expression of IP-IO fusion protein was induced with IPTG and purified using the Ni2+ affinity chromatography. The bioaetivity of IP-10 fusion protein was detected by transwell migration assay. [ Results ] The constructed recombinant plasmid pET-32a (+)- IP10 was correct, which was identified by DNA sequencing. The relative molecular mass (Mr) of the expressed prod- ucts was 37 000 with expected molecular weight. The satisfactory chemotactic activity of IP-10 was detected by transwell migration assay on activated T cells. [ Conclusion ] The fusion protein of pET-32a(+)-IP10 with bioactivity is expressed successfully in E. coli.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第23期3521-3524,3528,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(No:30470613) 教育部博士点专项基金(No:20040610053)
关键词 γ-干扰素诱导蛋白-10 融合蛋白 生物学活性 IFN-γ-inducible protein-10 fusion protein bioactivity
  • 相关文献

参考文献2

二级参考文献20

  • 1杨化新,沈佳,刘金秀.电位滴定法测定胰激肽释放酶活力测试条件探讨[J].药物分析杂志,1994,14(2):9-12. 被引量:7
  • 2Richard M,Ransohoff,Pia Kivisakk,et al.Three or more routes for leukocyte migration into the central nervous system[J].Nat Rev Immunol,2003,3:569-581
  • 3Engelhardt B,Ransohoff RM.The ins and outs of T-lymphocyte trafficking to the CNS:anatomical sites and molecular mechanisms[J].Trends Immunol.2005,26:485-495
  • 4Engelhardt B.Molecular mechanisms involved in T cell migration across the blood-brain barrier[J].J Neural Transm,2006,113:477-485
  • 5Piccio L,Rossi B,Scarpini E,et al.Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels; critical roles for Pselectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors[J].J Immunol,2002,168:1940-1949
  • 6Muller DM,Pender MP,Greer JM.Chemokine and chemokine receptors:potential therapeutic targets in multiple sclerosis[J].Curr Drug Targets Inflamm Allergy,2004,3:279-290
  • 7Quandt J,Dorovini-Zis K.The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4+T cell subsets to human brain endothelial cells[J].J Neuropathol Exp Neurol,2004,63:350-3625
  • 8Séguin R,Biemacki K,Rotondo RL,et al.Regulation and functional effects of monocyte migration across human brain-derived endothelial cells[J].J Neuropathol Exp Neurol,2003,62:412-419
  • 9Sunnemark D,Eltayeb S,Nilsson M,et al.CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis:kinetics and cellular origin[J].J Neuroinflammation,2005,29:17
  • 10Jalonen TO,Pulkkinen K,Ukkonen M,et al.Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes[J].J Neurol 2002; 249:576-583

共引文献4

同被引文献14

  • 1GARCIA L J, ROMA T J, MAYAN O, et al. Assessment of immunotoxicity parameters in individuals occupationally exposed to lead[J]. Journal of Toxicology an Envirod- nmental Health-Part A, 2012, 75 (13-15) : 807-818.
  • 2LEE EY, SEO M R, JUHNN Y S, et al. Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expres- sion in rheumatoid arthritis[J]. Arthritis Research and Therapy, 2011, 13(3): 173-174.
  • 3ALSLEBEN N, RUHWALD M, RUSSMANN H, et al. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: A case-control study[J]. Scandinavian Journal of Infectious Diseases, 2012, 44(4): 256-262.
  • 4KABEER BSA, PARAMASIVAM P, RAJA A. Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection [J]. Journal of Infection, 2012, 64(6): 573-579.
  • 5WANG Y, ZHAO C, ZHANG L, et al. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients[J]. AntiviralResearch, 2014, 103: 501-509.
  • 6王峰,杨文杰,成子锋,黄璐圆.人锰超氧化物歧化酶的扩增和表达研究[J].药物生物技术,2009,16(4):302-305. 被引量:4
  • 7樊欣迎,包乐媛,窦苓,杜连祥,路福平.融合蛋白EGFRi-IL-24的纯化及活性鉴定[J].药物生物技术,2009,16(4):321-324. 被引量:2
  • 8胡慧珍,思汗.干扰素的研究进展[J].当代畜禽养殖业,2009(12):5-9. 被引量:2
  • 9接振旺,贾晓健,钱杰,吴梧桐,张玉彬.胞红蛋白表达纯化及抗氧化活性研究[J].药物生物技术,2010,17(1):45-49. 被引量:4
  • 10赵鸿.干扰素生物活性两种测定方法的比较研究[J].中国医药导报,2010,7(10):36-38. 被引量:2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部